0
0

Cart (0)

Home > Isotope Labelled Standards > Mirogabalin

Mirogabalin - Isotope Labelled Standards
Wishlist
Select options

Mirogabalin besylate D5

  • CAT NUMBER DCTI-A-415
  • CAS NUMBER NA
  • MOLECULAR FORMULA C18H20D5NO5S (Salt); C12H14D5NO2 (Free Base)
  • MOLECULAR WEIGHT 372.49(Salt); 214.32 (Free Base)
Select options
Wishlist
References
FAQ's

References

  1. Burgess, J; Javed, S; Frank, B; Malik, R A; Alam, U., Mirogabalin besylate in the treatment of neuropathic pain, Drugs of today (Barcelona, Spain : 1998), Volume: 56, Issue: 2, Pages: 135-149, 2020 DOI: (1358/dot.2020.56.2.3100504)
  2. Shimada, Kousei; Kawamura, Asuka; Arakawa, Naohisa; Domon, Yuki, Bicyclic -amino acid derivative, EP2192109B1, Sep 25, 2008, Daiichi Sankyo Co., Ltd., Japan (https://www.lens.org/lens/search/patent/list?q=EP2192109)

Frequently Asked Questions

Side reactions and by-products formed during the synthetic process are the source of Mirogabalin impurities.

The nitrosamine Mirogabalin impurities can be carcinogenic and affect human health. Hence, it is essential to remove them from the drug.

Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) method identifies Mirogabalin impurities.

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart